Medical News

RSS

Neuroscientists say that general anesthesia is a reversible coma

The brain under general anesthesia isn't "asleep" as surgery patients are often told -- it is placed into a state that is a reversible coma, according to three neuroscientists who have published an extensive review of general anesthesia, sleep and coma, in the Dec. 30 issue of The New England Journal of Medicine.

30 Dec 2010

Intellipharmaceutics granted extension of deadline to regain compliance with Nasdaq Listing Rule

Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel or generic controlled release and targeted release oral solid dosage drugs, today announced that the staff of the Nasdaq Stock Market has granted the Company an extension of the deadline to regain compliance with Nasdaq Listing Rule 5550(b).

30 Dec 2010

LTC declares $0.50 per share quarterly cash dividend on Cumulative Preferred Stock

LTC Properties, Inc. announced today that it had declared the quarterly cash dividend of $0.50 per share on the Company's 8.0% Series F Cumulative Preferred Stock. The dividend is payable on January 14, 2011 to stockholders of record on January 7, 2011.

30 Dec 2010

Dosing initiated in combination Phase I study of palifosfamide with etoposide and cisplatin/carboplatin in SCLC

ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.

29 Dec 2010

New study confirms pancreas disease infects horizontally from population to population in seawater phase

Researchers and the salmon industry have been debating whether fingerling from freshwater farms can be a source of the virus that causes pancreas disease: salmonid alfavirus. The results of a new doctoral study show that this is not the case: pancreas disease transmits horizontally in the seawater phase and infection in fresh water has little bearing on how the disease spreads.

29 Dec 2010

FDA approves Impax's ANDA for generic Doryx 75 and 100mg tablets

Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.

29 Dec 2010

Positive results from OMS201 Phase 1/2 trial in patients undergoing urologic procedures

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced results from the Phase 1/2 clinical trial of OMS201, the Company's urological PharmacoSurgery™ product candidate.

29 Dec 2010

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Centocor Ortho Biotech Inc. announced today that it has filed a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) requesting the approval of REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.

29 Dec 2010

FDA approves Endo's FORTESTA Gel for low testosterone

Endo Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved FORTESTA Gel for the treatment of low testosterone, or 'Low T,' also known as hypogonadism. Symptoms associated with Low T include erectile dysfunction and decreased sexual desire, fatigue and loss of energy, mood depression, regression of secondary sexual characteristics and osteoporosis.

29 Dec 2010

CFTR protein regulates inflammation and cell death in emphysema, chronic lung diseases

A team of Johns Hopkins Children's Center researchers has discovered that a protein involved in cystic fibrosis also regulates inflammation and cell death in emphysema and may be responsible for other chronic lung diseases.

29 Dec 2010

New study reports close association between obesity and fibromyalgia

Afflicting up to 5 percent of the U.S. population, mostly women, fibromyalgia is characterized by widespread pain and range of function problems. A new study in The Journal of Pain reports there is close association between obesity and disability in fibromyalgia patients.

29 Dec 2010

CEL-SCI initiates Multikine Phase III trail for head and neck cancer

CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy. CEL-SCI has now completed all of the manufacturing and regulatory requirements to begin enrollment of the study.

29 Dec 2010

Winter grips Scotland with unprecedented rise in health concerns

Over three days of festivities Scotland’s NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24’s busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.

29 Dec 2010

Free nicotine patches to help smokers quit this New Year

British smokers thinking of quitting have a reason to celebrate this New Year. Free nicotine patches are to be offered on the NHS as part of a major drive to help smokers quit. The Department of Health has announced that smokers would be given coupons for a week’s free trial of the patches in the “Quit kits”. The patches included in the kit will be either NiQuitin Clear 21mg patches or Nicotinell TTS 30 21mg/24 hour patches, Step 1.

29 Dec 2010

Epilepsy more common than earlier thought: Study

Epilepsy prevalence and incidence is greater than earlier thought in the United States. The latest study shows that one in every 26 people in the United States will develop epilepsy at some point in their life. Experts believe this new revelation calls for more attention and funding for the disease.

29 Dec 2010

FDA stops pain drug trial over safety concerns

Johnson & Johnson revealed Tuesday this week that a clinical trial of its experimental pain drug, fulranumab, has been stopped after the Food and Drug Administration expressed concerns that patients taking the drug could suffer increased joint damage.

29 Dec 2010

Experimental device for obstructive sleep apnea

Obstructive sleep apnea, a dangerous sleep disorder that affects millions of Americans may have found a cure. The disease commonly manifested as snoring but leading to tremendous sleep deprivation can be severely debilitating. Sleep deprivation may lead to car crashes, accidents, high blood pressure, heart attack, stroke, and diabetes.

29 Dec 2010

Controlling the amount of adipose tissue is key to combat obesity

Obesity is seen as the great pandemia of the XXI century. Recent data point to more than a billion adults in the world suffering from overweight, of which 300 million are clinically obese. What is more, the rates of child obesity show a worrying increase, with more than 155 million children and adolescents being overweight, of which 40 million are clearly obese.

29 Dec 2010

Merck confirms plans for developing vernakalant drug for atrial fibrillation

Cardiome Pharma Corp. today announced that it has been advised by its partner, Merck, that the current review of vernakalant is complete, and that Merck has informed Cardiome of its next steps in clinical development for vernakalant beginning in 2011.

29 Dec 2010

Primal fitness offer tips that help you get in shape for 2011

For your New Year's fitness resolution, why not turn to something new, but at the same time, very old? A new trend, called Primal fitness, involves practicing activities that our early hunter-gatherer ancestors would have experienced in the wild - movements such as walking, running, balancing, climbing, lifting, carrying, throwing and catching.

29 Dec 2010

Medical News

Neuroscientists say that general anesthesia is a reversible coma

Intellipharmaceutics granted extension of deadline to regain compliance with Nasdaq Listing Rule

LTC declares $0.50 per share quarterly cash dividend on Cumulative Preferred Stock

Dosing initiated in combination Phase I study of palifosfamide with etoposide and cisplatin/carboplatin in SCLC

New study confirms pancreas disease infects horizontally from population to population in seawater phase

FDA approves Impax's ANDA for generic Doryx 75 and 100mg tablets

Positive results from OMS201 Phase 1/2 trial in patients undergoing urologic procedures

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

FDA approves Endo's FORTESTA Gel for low testosterone

CFTR protein regulates inflammation and cell death in emphysema, chronic lung diseases

New study reports close association between obesity and fibromyalgia

CEL-SCI initiates Multikine Phase III trail for head and neck cancer

Winter grips Scotland with unprecedented rise in health concerns

Free nicotine patches to help smokers quit this New Year

Epilepsy more common than earlier thought: Study

FDA stops pain drug trial over safety concerns

Experimental device for obstructive sleep apnea

Controlling the amount of adipose tissue is key to combat obesity

Merck confirms plans for developing vernakalant drug for atrial fibrillation

Primal fitness offer tips that help you get in shape for 2011

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News